Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Zyprexa Reduced Hospitalization Rate In CATIE Study Is Key For Payors, Lilly Says

Oct 20 2005

• By Andrew Shelton

Related Content

Lilly To Pay Up To $690 Mil. To Settle Majority Of Zyprexa Injury Claims

Jun 10 2005

Zyprexa Ekes Out Narrow Lead In Schizophrenia Study, But Efficacy Is Offset By Side Effects

Sep 19 2005

Additional Topics

BioPharmaceutical

More from Archive

More from Pink Sheet

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window